Delos Capital Partners
Overview
Delos Capital Partners is a venture capital firm that invests in seed, early, and later-stage companies in the healthcare, life sciences, and technology sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Imperative Care | Jul 2021 | Series D | - |
| Avenzo Therapeutics | Sep 2025 | Series B | Co-investor |
| Eccogene | Jun 2023 | Series B | Co-investor |
| Sirius Therapeutics, Inc. | Oct 2023 | Series B | Co-investor |
| Instylla | Aug 2023 | Series C | Lead |
For institutional investors. Book with your work email.
Key People
Henry Chen
Founder And Managing Partner
Matt Constantino
Founding Partner
Ari Lefkovits
Managing Partner
Daniel A. Davis
Operating Partner
Eric Huang
Partner
Tim Xiao
Partner
Dan Li
Principal
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Delos Capital Partners based?
Delos Capital Partners is headquartered in Cambridge, Massachusetts, United States.
When was Delos Capital Partners founded?
Delos Capital Partners was founded in 2014.
How many portfolio companies does Delos Capital Partners have?
Delos Capital Partners has 26 portfolio companies in Caplight's dataset.
What are some companies in Delos Capital Partners's portfolio?
Portfolio companies visible on Caplight include Imperative Care, Avenzo Therapeutics, Eccogene, Sirius Therapeutics, Inc., Instylla.
What was Delos Capital Partners's most recent investment shown here?
Delos Capital Partners's most recent investment in this portfolio sample was in Avenzo Therapeutics in 2025.
What sectors does Delos Capital Partners focus on?
Delos Capital Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Delos Capital Partners focus on?
Delos Capital Partners typically invests at the Mid stage.
What is Delos Capital Partners's AUM?
Delos Capital Partners's assets under management are estimated between $250.0M and $500.0M.